{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T07:34:05Z","timestamp":1649057645914},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T00:00:00Z","timestamp":1423180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Brasileira de Hematologia e Hemoterapia"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.bjhh.2015.02.003","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T06:27:38Z","timestamp":1424154458000},"page":"109-114","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A model for the functional assessment of elderly with myeloid neoplasms"],"prefix":"10.1016","volume":"37","author":[{"given":"Ana L\u00facia Ippolito","family":"Carbonell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata Maceu","family":"Salhab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Giampaoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maysa Seabra","family":"Cendoroglo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria de Lourdes","family":"Chauffaille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bjhh.2015.02.003_bib0135","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1590\/S1516-84842010005000091","article-title":"Neoplasias mieloproliferativas: revis\u00e3o dos crit\u00e9rios diagn\u00f3sticos e dos aspectos cl\u00ednicos","volume":"32","author":"Chauffaille","year":"2010","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"8","key":"10.1016\/j.bjhh.2015.02.003_bib0140","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1016\/S1470-2045(12)70234-6","article-title":"Treatment decisions for elderly patients with haematological malignancies: a dilemma","volume":"13","author":"Peyrade","year":"2012","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.bjhh.2015.02.003_bib0145","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3324\/haematol.13309","article-title":"Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia","volume":"93","author":"Malfuson","year":"2008","journal-title":"Haematologica"},{"issue":"22","key":"10.1016\/j.bjhh.2015.02.003_bib0150","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1182\/blood-2010-03-276485","article-title":"Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia","volume":"116","author":"Kantarjian","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bjhh.2015.02.003_bib0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3816\/CLML.2011.n.001","article-title":"Treatment of unfit patients with acute myeloid leukemia: a still open clinical challenge","volume":"11","author":"Ferrara","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.bjhh.2015.02.003_bib0160","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3324\/haematol.2011.044776","article-title":"Treatment of acute myeloid leukemia in the elderly","volume":"96","author":"Estey","year":"2011","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.bjhh.2015.02.003_bib0165","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJM199909303411407","article-title":"Acute myeloid leukemia","volume":"341","author":"Lowenberg","year":"1999","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.bjhh.2015.02.003_bib0170","first-page":"1513","article-title":"Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches","volume":"91","author":"Deschler","year":"2006","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.bjhh.2015.02.003_bib0175","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1590\/S1807-59322011000800005","article-title":"Improving the outcomes of elderly patients with acute myeloid leukemia in a Brazilian University Hospital","volume":"66","author":"Sandes","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"issue":"4","key":"10.1016\/j.bjhh.2015.02.003_bib0180","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L","article-title":"The use of the nitrogen mustards in the palliative treatment of carcinoma \u2013 with particular reference to Bronchogenic carcinoma","volume":"1","author":"Karnofsky","year":"1948","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bjhh.2015.02.003_bib0185","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0021-9681(60)90137-5","article-title":"Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide","volume":"11","author":"Zubrod","year":"1960","journal-title":"J Chronic Dis"},{"issue":"2","key":"10.1016\/j.bjhh.2015.02.003_bib0190","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1200\/JCO.20.2.494","article-title":"Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study","volume":"20","author":"Repetto","year":"2002","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.bjhh.2015.02.003_bib0195","first-page":"1","article-title":"The geriatric cancer patient: equal benefit from equal treatment","volume":"8","author":"Balducci","year":"2001","journal-title":"Cancer Control"},{"issue":"14","key":"10.1016\/j.bjhh.2015.02.003_bib0200","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1200\/JCO.2007.10.6559","article-title":"Comprehensive geriatric assessment for older patients with cancer","volume":"25","author":"Extermann","year":"2007","journal-title":"J Clin Oncol"},{"issue":"February (2)","key":"10.1016\/j.bjhh.2015.02.003_bib0205","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3324\/haematol.2012.067892","article-title":"Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome","volume":"98","author":"Deschler","year":"2013","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.bjhh.2015.02.003_bib0210","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","article-title":"Studies of illness in the aged. The index of Adl: a standardized measure of biological and psychosocial function","volume":"185","author":"Katz","year":"1963","journal-title":"J Am Med Assoc"},{"issue":"3","key":"10.1016\/j.bjhh.2015.02.003_bib0215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"key":"10.1016\/j.bjhh.2015.02.003_bib0220","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"issue":"8","key":"10.1016\/j.bjhh.2015.02.003_bib0225","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bjhh.2015.02.003_bib0230","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2471\/BLT.08.050955","article-title":"The Declaration of Helsinki and public health","volume":"86","author":"Williams","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.bjhh.2015.02.003_bib0235","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2288-11-77","article-title":"Logistic random effects regression models: a comparison of statistical packages for binary and ordinal outcomes","volume":"11","author":"Bauyoe","year":"2011","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.bjhh.2015.02.003_bib0240","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11336-003-1108-y","article-title":"Multilevel model prediction","volume":"71","author":"Frees","year":"2006","journal-title":"Psychometrika"},{"issue":"4","key":"10.1016\/j.bjhh.2015.02.003_bib0245","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1182\/blood.V98.4.958","article-title":"Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes","volume":"98","author":"Raza","year":"2001","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.bjhh.2015.02.003_bib0265","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1182\/blood-2010-01-263624","article-title":"Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase","volume":"115","author":"Pavlu","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bjhh.2015.02.003_bib0255","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s12032-014-0869-8","article-title":"Contribution of comorbidities and grade of bone marrow fibrosis to the prognosis of survival in patients with primary myelofibrosis","volume":"31","author":"Lekovic","year":"2014","journal-title":"Med Oncol"},{"issue":"5","key":"10.1016\/j.bjhh.2015.02.003_bib0260","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"5","key":"10.1016\/j.bjhh.2015.02.003_bib0250","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3324\/haematol.2010.036715","article-title":"Quality of life in elderly patients with acute myeloid leukemia: patients may be more accurate than physicians","volume":"96","author":"Oliva","year":"2011","journal-title":"Haematologica"}],"container-title":["Revista Brasileira de Hematologia e Hemoterapia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1516848415000274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1516848415000274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T05:27:58Z","timestamp":1537853278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1516848415000274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1516848415000274"],"URL":"https:\/\/doi.org\/10.1016\/j.bjhh.2015.02.003","relation":{},"ISSN":["1516-8484"],"issn-type":[{"value":"1516-8484","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A model for the functional assessment of elderly with myeloid neoplasms","name":"articletitle","label":"Article Title"},{"value":"Revista Brasileira de Hematologia e Hemoterapia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjhh.2015.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}